Expertise in
7
conditions

Jayesh R. Desai

305 Grattan St, 
Melbourne, VIC, AU 
Expertise in
7
conditions
305 Grattan St, 
Melbourne, VIC, AU 

Overview

Jayesh Desai practices practicing medicine in Melbourne, Australia.

Mr. Desai is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Synovitis, Tenosynovitis, and PIK3CA-Related Overgrowth Spectrum.

He is actively involved in clinical research, co-authoring 181 peer reviewed articles and participating in 8 clinical trials.

Gender

Male

Locations

305 Grattan St, Melbourne, VIC 3000, Australia
Other Locations
Grattan Street, Prahran, VIC 3050, Australia
St Andrews Place, East Melbourne, VIC 3002, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Phase I First Time in Human Open Label Study of GSK3745417 Administered With and Without Anticancer Agents in Participants With Advanced Solid Tumors
A Phase I First Time in Human Open Label Study of GSK3745417 Administered With and Without Anticancer Agents in Participants With Advanced Solid Tumors
Enrollment Status: Terminated
Publish Date: August 03, 2026
Intervention Type: Drug
Study Phase: Phase 1
Phase 1-2 Study Investigating Safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of Various Combinations of BGB-A425 and LBL-007 With Tislelizumab in Patients With Advanced Solid Tumors
Phase 1-2 Study Investigating Safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of Various Combinations of BGB-A425 and LBL-007 With Tislelizumab in Patients With Advanced Solid Tumors
Enrollment Status: Completed
Publish Date: April 02, 2026
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
A First-in-Human Phase I Trial of ATG-101 in Patients With Metastatic/Advanced Solid Tumors and Mature B-cell Non-Hodgkin Lymphomas
A First-in-Human Phase I Trial of ATG-101 in Patients With Metastatic/Advanced Solid Tumors and Mature B-cell Non-Hodgkin Lymphomas
Enrollment Status: Terminated
Publish Date: June 09, 2025
Intervention Type: Drug
Study Drug: ATG-101
Study Phase: Phase 1
Master Protocol to Assess the Safety and Recommended Phase 2 Dose of Next Generations of Autologous Enhanced NY-ESO-1/ LAGE-1a TCR Engineered T-cells, Alone or in Combination With Other Agents, in Participants With Advanced Tumors
Master Protocol to Assess the Safety and Recommended Phase 2 Dose of Next Generations of Autologous Enhanced NY-ESO-1/ LAGE-1a TCR Engineered T-cells, Alone or in Combination With Other Agents, in Participants With Advanced Tumors
Enrollment Status: Terminated
Publish Date: November 26, 2024
Intervention Type: Drug
Study Drugs: GSK3901961, GSK3845097, Fludarabine, Cyclophosphamide
Study Phase: Phase 1
A Phase I, Open-Label, Multi-Center Dose Finding Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of ATG-017 Monotherapy or Combination Therapy With Nivolumab in Patients With Advanced Solid Tumors and Hematological Malignancies
A Phase I, Open-Label, Multi-Center Dose Finding Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of ATG-017 Monotherapy or Combination Therapy With Nivolumab in Patients With Advanced Solid Tumors and Hematological Malignancies
Enrollment Status: Terminated
Publish Date: July 23, 2024
Intervention Type: Drug
Study Phase: Phase 1
Safety and Oversight of the Individually Tailored Treatment Approach: A Novel Pilot Study
Safety and Oversight of the Individually Tailored Treatment Approach: A Novel Pilot Study
Enrollment Status: Terminated
Publish Date: May 10, 2023
Intervention Type: Drug
Study Phase: Not Applicable
A Phase 1b (Open-Label)/Phase 2 (Randomized, Double-Blinded) Study Evaluating Gemcitabine and Docetaxel With or Without Olaratumab in the Treatment of Advanced Soft Tissue Sarcoma
A Phase 1b (Open-Label)/Phase 2 (Randomized, Double-Blinded) Study Evaluating Gemcitabine and Docetaxel With or Without Olaratumab in the Treatment of Advanced Soft Tissue Sarcoma
Enrollment Status: Completed
Publish Date: May 09, 2022
Intervention Type: Drug
Study Drugs: Olaratumab, Gemcitabine, Docetaxel
Study Phase: Phase 1/Phase 2
A Phase I, Dose Escalation Study of BNC101 (Anti-LGR5 Humanized Monoclonal Antibody) in Patients With Metastatic Colorectal Cancer.
A Phase I, Dose Escalation Study of BNC101 (Anti-LGR5 Humanized Monoclonal Antibody) in Patients With Metastatic Colorectal Cancer.
Enrollment Status: Terminated
Publish Date: January 16, 2019
Intervention Type: Drug
Study Phase: Phase 1
View 7 Less Clinical Trials

181 Total Publications

Genomic Therapy Matching in Rare and Refractory Cancers.
Genomic Therapy Matching in Rare and Refractory Cancers.
Journal: JAMA oncology
Published: March 05, 2026

Frequently Asked Questions about Jayesh R. Desai

Is Jayesh R. Desai a top-rated expert for Colorectal Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Jayesh R. Desai is classified as an Elite expert for Colorectal Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Jayesh R. Desai participate in research or clinical trials?

Yes. Jayesh R. Desai has published 181 articles and abstracts on conditions like Colorectal Cancer. You can view a list of Jayesh R. Desai's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Desai's expertise for a condition
ConditionClose
View All 20 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile